The impact of tertiary lymphoid structures on clinicopathological, genetic and gene expression characteristics in lung adenocarcinoma.
Tamiya Y, Nakai T, Suzuki A, Mimaki S, Tsuchihara K, Sato K, Yoh K, Matsumoto S, Zenke Y, Nosaki K, Izumi H, Shibata Y, Sakai T, Taki T, Miyazaki S, Watanabe R, Sakamoto N, Sakashita S, Kojima M, Hashimoto N, Tsuboi M, Goto K, Ishii G.
Tamiya Y, et al. Among authors: sato k.
Lung Cancer. 2022 Dec;174:125-132. doi: 10.1016/j.lungcan.2022.11.001. Epub 2022 Nov 5.
Lung Cancer. 2022.
PMID: 36379125